WTFG
NVS icon

Wells Trecaso Financial Group’s Novartis NVS Stock Holding History

Wells Trecaso Financial Group’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,551
Closed -$241K – 73
2019
Q4 		$241K Buy
2,551
+205
+9% +$18.4K 0.17% 64
2019
Q3 		$204K Sell
2,346
-9
-0.4% -$808 0.16% 64
2019
Q2 		$215K Sell
2,355
-105
-4% -$8.89K 0.18% 63
2019
Q1 		$212K Buy
+2,460
New +$197K 0.18% 66

Other funds holding NVS

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Wells Trecaso Financial Group's NVS Position: Q1 2020 in Review

Wells Trecaso Financial Group sold out of Novartis (NVS) in Q1 2020, closing a stake of 2,551 shares — an estimated $241K sold.

Wells Trecaso Financial Group first reported a position in NVS in Q1 2019 and held it in 4 quarters. The position peaked at $241K in Q4 2019. 1,134 funds tracked by Wall St. Rank hold NVS as of Q1 2020.

  • Wells Trecaso Financial Group reported no remaining Novartis position as of Q1 2020 after selling out during the quarter.
  • Wells Trecaso Financial Group sold 2,551 Novartis shares in Q1 2020, an estimated $241K.
  • Wells Trecaso Financial Group first reported a position in Novartis in Q1 2019 and held it in 4 quarters.
  • Wells Trecaso Financial Group's Novartis position peaked at $241K in Q4 2019.
  • 1,134 funds tracked by Wall St. Rank held Novartis as of Q1 2020.

Based on Wells Trecaso Financial Group's 13F filing for Q1 2020, filed 17 Apr 2020.